OMass Therapeutics
A biotechnology company using mass spectrometry platforms for drug discovery and the development of therapeutics.
1
Funding Rounds
$100.0m
Money raised
Overview
A biotechnology company using mass spectrometry platforms for drug discovery and the development of therapeutics.
-
Website:
- Business model: B2B
- Social accounts:
| Name | Phone | Social networks | |
|---|---|---|---|
| Id*** Li** |
|
- | - |
Funding series
Funding Series Analysis
The company OMass Therapeutics has raised a total of $100m in funding over 1 rounds.
Key Insights:
- OMass Therapeutics Series B round, April 28, 2022: $100m
OMass Therapeutics Series B round, April 28, 2022
$100m
Industries
OMass Therapeutics is active in the following industries: